Daniel O'Connell
Partner
Novo Holdings
Bio:
Daniel O’Connell MD, PhD, joined Novo Holdings in 2022 as Partner in the Venture Investments team, based in the San Francisco office.
Prior to joining Novo Holdings, Daniel was Head of Equity and Venture Capital at BMS. He has been an investor focused on private biotech opportunities at Arix Bioscience and OrbiMed, and started his career in operations at Arisaph Pharmaceuticals.
Daniel completed his undergraduate degrees at MIT and obtained his MD and PhD from Tufts University.